Your DNA falls into the realm of “the world’s info,” and it seems that Google, as part of its corporate mission, is making a play to organize that, too. The World Wide Web giant received heavy press in 2007 when it invested at least $4.4 million in a genetic screening company, 23andMe, that was started by Anne Wojcicki, the wife of Google co-founder Sergey Brin, and her business partner.

Google’s interest in DNA doesn’t end there. It is plus putting money into a second Silicon Valley DNA-screening startup, Navigenics. The company is plus backed by star venture capital firm Kleiner, Perkins, Caufield & Byers. For a spit of saliva and $2,500, your genetic pop quiz results are securely delivered to your computer screen with your genetic likelihood for 18 medical conditions, from Alzheimer’s to rheumatoid arthritis to several types of cancer. Navigenics aims to boost disease prevention by providing customers reports on their DNA that they can share with

their doctors. The company addresses privacy concerns by encrypting customer identities, and screens only for conditions it deems to have scientifically sound genetic studies. The company plus offers genetic counseling.

Much in the way it invested in 23andMe, Google wants to plant an early stake in a potentially large new market around genetic details. “We are interested in supporting companies and making investments in companies that [bolster] our mission statement, which is organizing the world’s info and making it universally accessible and useful,” Google spokesman Andrew Pederson says.

Size of Investment Not Disclosed

Calling 23andMe an example of a company “generating a whole new batch of info of interest to a broad range of society,” Pederson says Google wants to extend its capabilities into genetic examining. The precise path and business contours of the emerging gene-testing market remain unclear, but whether Navigenics succeeds it “will generate a lot…

Orginal post by Top Tech News